| 12173018 |
Penicillin-binding protein inhibitors |
Christopher J. Burns, Denis DAIGLE, Guo-Hua Chu, Jodie HAMRICK, Allison L. Zulli +5 more |
2024-12-24 |
|
| 12102648 |
Orally-bioavailable nucleoside analogs |
Christopher J. Burns, Glen COBURN, Guo-Hua Chu, Stephen M. Condon, Daniel C. Pevear |
2024-10-01 |
|
| 12084445 |
Broad-spectrum carbapenems |
Christopher J. Burns, Guo-Hua Chu, Jodie HAMRICK, Stephen M. Condon |
2024-09-10 |
|
| 11638715 |
Orally-bioavailable nucleoside analogs |
Christopher J. Burns, Glen COBURN, Guo-Hua Chu, Stephen M. Condon, Daniel C. Pevear |
2023-05-02 |
|
| 11566001 |
Hepatitis B capsid assembly modulators |
Christopher J. Burns, Glen COBURN, Bin Liu, Jiangchao Yao, Christopher BENETATOS +2 more |
2023-01-31 |
|
| 11332485 |
Penicillin-binding protein inhibitors |
Christopher J. Burns, Denis DAIGLE, Guo-Hua Chu, Jodie HAMRICK, Matthew C. Lucas +5 more |
2022-05-17 |
|
| 11267826 |
Penicillin-binding protein inhibitors |
Christopher J. Burns, Denis DAIGLE, Guo-Hua Chu, Randy W. Jackson, Jodie HAMRICK +3 more |
2022-03-08 |
|
| 11247965 |
Hepatitis B capsid assembly modulators |
Christopher J. Burns, Glen COBURN, Bin Liu, Jiangchao Yao, Christopher BENETATOS +1 more |
2022-02-15 |
|
| 11046716 |
Beta-lactamase inhibitors |
Christopher J. Burns, Bin Liu, Jiangchao Yao, Denis DAIGLE |
2021-06-29 |
|
| 11014881 |
Hepatitis B capsid assembly modulators |
Christopher J. Burns, Glen COBURN, Bin Liu, Jiangchao Yao, Christopher BENETATOS +2 more |
2021-05-25 |
|
| 10590076 |
Hepatitis B capsid assembly modulators |
Christopher J. Burns, Glen COBURN, Bin Liu, Jiangchao Yao, Christopher BENETATOS +2 more |
2020-03-17 |
|
| 10464952 |
Beta-lactamase inhibitors |
Christopher J. Burns, Daniel C. Pevear, Robert E. Lee TROUT, Randy W. Jackson, Jodie HAMRICK +2 more |
2019-11-05 |
|
| 10399996 |
Beta-lactamase inhibitors |
Christopher J. Burns, Bin Liu, Jiangchao Yao, Denis DAIGLE |
2019-09-03 |
|
| 9914708 |
Benzoimidazol-1,2-yl amides as Kv7 channel activators |
Scott Harried, Lynn Resnick, George T. Topalov, Justin K. Belardi, Charles A. Flentge +3 more |
2018-03-13 |
|
| 9650376 |
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators |
Lynn Resnick, George T. Topalov, Justin K. Belardi, Charles A. Flentge, James S. Hale +8 more |
2017-05-16 |
|
| 9481653 |
Benzoimidazol-1,2-yl amides as Kv7 channel activators |
Lynn Resnick, George T. Topalov, Justin K. Belardi, Charles A. Flentge, James S. Hale +3 more |
2016-11-01 |
|
| 9133187 |
Serine/threonine kinase inhibitors |
James F. Blake, Huifen Chen, Mark Joseph Chicarelli, Jason Demeese, Rustam Ferdinand Garrey +11 more |
2015-09-15 |
$12,297,000 |
| 9079890 |
Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives |
Thomas D. Aicher, Mark Joseph Chicarelli, Kevin Ronald Condroski, Jay Bradford Fell, John P. Fischer +5 more |
2015-07-14 |
$14,749,000 |
| 8933077 |
Glucokinase activators |
Thomas D. Aicher, Wai-Man Lee, Ronald Jay Hinklin, Mark Joseph Chicarelli, Kevin Ronald Condroski |
2015-01-13 |
$3,576,000 |
| 8883828 |
2-aminopyridine analogs as glucokinase activators |
Thomas D. Aicher, Mark Joseph Chicarelli, Kevin Ronald Condroski, Ronald Jay Hinklin, Ajay Singh |
2014-11-11 |
$5,786,000 |
| 8853409 |
Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
Thomas D. Aicher, Mark Joseph Chicarelli, Kevin Ronald Condroski, Jay Bradford Fell, John P. Fischer +5 more |
2014-10-07 |
$1,724,000 |
| 8754226 |
Piperidinyl-substituted lactams as GPR119 modulators |
Thomas D. Aicher, Josef R. Bencsik, Kevin Ronald Condroski, Jay Bradford Fell, John P. Fischer +5 more |
2014-06-17 |
$6,789,000 |
| 8580780 |
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist |
John Gordon Allen, Karin Briner, Christopher Stanley Galka, Maria Angeles Martinez-Grau, Matthew Robert Reinhard +9 more |
2013-11-12 |
$216,055,000 |
| 8431713 |
2-aminopyridine derivatives as glucokinase activators |
Thomas D. Aicher, Mark Joseph Chicarelli, Kevin Ronald Condroski, Rustam Ferdinand Garrey, Ronald Jay Hinklin +2 more |
2013-04-30 |
$4,417,000 |
| 8362037 |
2-aminopyridine analogs as glucokinase activators |
Thomas D. Aicher, Mark Joseph Chicarelli, Kevin Ronald Condroski, Ronald Jay Hinklin, Ajay Singh |
2013-01-29 |
$3,041,000 |
